Skip to content

Study of safety and antitumor activity of GEN1056 in participants with advanced solid tumors

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-514357-29-00
Acronym
GCT1056-01
Enrollment
18
Registered
2024-10-02
Start date
2022-11-04
Completion date
2025-10-23
Last updated
2024-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced solid tumors

Interventions

None listed

Sponsors

Genmab A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026